Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Aptamers Market Valued at Present and by 2029?

The market for aptamers has seen exceptional growth in the recent past. Projected to increase from $2.65 billion in 2024 to $3.25 billion in 2025, the market’s compound annual growth rate (CAGR) will be 22.6%. The historic period growth can be traced back to the demand for high-specificity binders, the therapeutic potential they hold, the surge in personalized medicine, prospects in therapeutic areas, alternatives to antibodies, and diagnostic point-of-care (POC) devices.

The aptamers market size is projected to experience significant expansion in the coming years. It is predicted to increase to $7.87 billion in 2029 with a compound annual growth rate (CAGR) of 24.7%. This forecasted growth is due to increased investment in life sciences, drug development expansion, the progress of cancer research, rapid detection in emergency scenarios, improvement in aptamer selection methods, and regulatory backing. Notable trends during this forecast period are advancements in selex technology, growth in diagnostic applications, investment in aptamer research, the contribution of nanotechnology, and efforts in awareness and education.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8156&type=smp

#What Drivers Are Influencing Growth In The Aptamers Market?

The aptamers market is experiencing growth, propelled by the escalating prevalence of chronic respiratory diseases. These diseases are characterised by the narrowing and swelling of airways, often accompanied by the production of excess mucus. This leads to difficulties in breathing, coughing, discomfort in breathing, and wheezing upon release of breath. Aptamers serve an important role in the identification of the respiratory syncytial virus (RSV), facilitating early detection and subsequent treatment of the disease. To illustrate, the Australian Institute of Health and Welfare reported in June 2024 that COPD represented 3.6% of the overall disease burden and accounted for 50% of respiratory disease-related burdens in 2023. Further, there were 7,691 deaths in 2022 attributed to COPD, equivalent to 29.6 per 100,000 population, contributing 4.0% of all deaths in Australia that year. This increasing occurrence of chronic respiratory diseases is therefore fostering the growth of the aptamers market.

What Are The Main Segments Identified In The Aptamers Market Research?

The aptamers market covered in this report is segmented –

1) By Type: DNA Aptamers, XNA Aptamers, RNA Aptamers

2) By Technology: SELEX, X Aptamer, Maras Technique

3) By Application: Therapeutics Development, Research and Development, Diagnostic, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Cathode-Ray Oscilloscope, Other End Users

Subsegments:

1) By DNA Aptamers: Single-Stranded DNA (ssDNA) Aptamers, Double-Stranded DNA (dsDNA) Aptamers

2) By XNA Aptamers: Peptide Nucleic Acid (PNA) Aptamers, Locked Nucleic Acid (LNA) Aptamers, Glycyl Nucleic Acid (GNA) Aptamers

3) By RNA Aptamers: Small Interfering RNA (siRNA) Aptamers, Short Hairpin RNA (shRNA) Aptamers, Long Non-Coding RNA (lncRNA) Aptamers

What Are The Leading Trends And Opportunities In The Aptamers Sector?

Technological advances are emerging as dominant trends in the aptamers industry. To maintain market dominance, top-tier firms are adopting modern technologies like artificial DNA aptamers, fabricated through flexible and smooth technology. For example, in August 2023, the FDA greenlighted Izervay for treating geographic atrophy due to age-caused macular degeneration. Izervay presents an innovative approach to stall geographic atrophy progression, providing a glimmer of hope for those affected by this severe type of macular degeneration. This treatment is designed to decelerate the withering of retinal cells linked to the condition, signifying a monumental leap in the field of vision care.

Which Companies Play A Key Role In The Development Of The Aptamers Market?

Major companies operating in the aptamers market are Aptamer Group Limited, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies Inc., AMS Biotechnology Ltd., Vivonics Inc., TriLink Biotechnologies LLC, Noxxon Pharma SE, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, Novaptech Inc., Maravai Lifesciences Inc., Bio-Techne Corporation, Creative Biolabs Inc., IBA Lifesciences GmbH, Aptabharat Innovations Pvt. Ltd., Profacgen Biotech Inc., Medi GmbH & Co. KG, Pure Biologics Sp. z o.o., Oak BioSciences Inc., Ophthotech Corporation, Novartis AG, NeoNeuro SAS, CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca PLC, GlyTech Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies Inc., IVERIC bio Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/aptamers-global-market-report

What Are The Key Regional Developments Shaping The Aptamers Market?

North America was the largest region in the aptamers market in 2024. The regions covered in the aptamers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8156&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model